PHARM.ASPHARM.ASAMS
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-52.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-52.9%/yr
vs +12.8%/yr prior
Acceleration
-65.7pp
Decelerating
Percentile
P50
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 6.46% |
| 2023 | 31.19% |
| 2022 | -21.80% |
| 2021 | 62.01% |
| 2020 | 30.48% |
| 2019 | -3.82% |
| 2018 | 47.61% |
| 2017 | 38.31% |
| 2016 | 4.39% |
| 2015 | 9.31% |